Healthcare -
Biotechnology - NASDAQ - US
$ 5.5
5.16 %
$ 49 M
Market Cap
-11.22
P/E
ICCC - COST OF REVENUE
Cost of Revenue ICCC - ImmuCell Corporation
13.1 M
LAST VALUE
11.13%
2 YEAR CAGR
17.69%
5 YEAR CAGR
16.07%
10 YEAR CAGR